entertainment -WSS

entertainment

author：hotspot 2025-09-30 12:21:41 - browse：59

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Criminal prosecution for violating HIPAA: an emerging threat

hotspot

WSS

Wearables generate powerful data but its not useful to doctors, yet

Biogen shutters digital health group, ends Apple study, in cost cutting move

How one patient went off dialysis — and others can too

Menendez indictment could see pharma lose a key ally

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Covid vaccines: Private market messier than government rollout

hotspot

entertainment

hotspot

Hollywood unions extend contract negotiations for actors

Helping hospitals and community health centers plan for resilience

Psychedelics group wrestles with new pharma identity

Case highlights the risks of experimental stem cell therapy

The high cost of giving birth even with insurance

Researchers use wearables data and AI to predict preterm birth risk

Heart attack and stroke risk calculators need revising

How the Dana

Medical leaders decry Supreme Court decision on affirmative action

Anxious about a speech? A startup wants you to pop a minty cardiac drug

focus

Mindstrong's demise and the future of mental health care

Wearables generate powerful data but its not useful to doctors, yet

FDA advisers vote against ALS treatment from BrainStorm

Inequities make cancer less preventable for women: report

Menendez indictment could see pharma lose a key ally

Researchers use wearables data and AI to predict preterm birth risk

leisure time

hotspot

focus

hotspot